We read with interest the review by Rahim et al.,(1) in which they gave an elegant summary
of the role, predictors, and optimal timing of corticosteroids and liver transplantation (LT) in …

Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the
transplant community. As a disease, it is poorly characterized, and there is a weak evidence …

We read with interest the review article by Rahim et al.(1) who summarized acute
autoimmune hepatitis (AIH), acute-severe AIH, and acute-severe AIH with acute liver failure …

We read with great interest the manuscript entitled ''Prognosis of acute severe autoimmune
hepatitis (AS-AIH): The role of corticosteroids in modifying outcome''by Yeoman et al.[1] …

Aims The definition of original acute severe autoimmune hepatitis (AS‐AIH) is unclear.
However, its rapid recognition and early treatment is potentially life‐saving. Therefore, we …

Abstract Background and Aims Acute severe autoimmune hepatitis (AS‐AIH) is an evolving
concept and the outcomes and optimal treatment have been less studied. In this study, we …

Background & Aims No standardised definition exists for acute, severe AIH (AS-AIH).
However, rapid identification of AS-AIH and early corticosteroid therapy may prevent the …

Summary Background and Aims To assess whether corticosteroids improve prognosis in
patients with AS‐AIH, and to identify factors at therapy initiation and during therapy …

We read with great interest the paper by Yeoman et al. published in the October 2014 issue
of the Journal of Hepatology [1]. Based on a well-characterized cohort of 32 patients with …

Autoimmune hepatitis (AIH) can present as acute hepatitis in its onset of symptoms and
features, progressing to severe hepatitis and acute liver failure. In a recent national survey in …